glucosylceramide synthase inhibitor (CerRx)

N/A

Report date: 2025/03/20 14:59:32
NME

Base Information

Drug Nameglucosylceramide synthase inhibitor (CerRx)
Drug Alias Name1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (CerRx)PPMP (CerRx)PPMP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCeramide glucosyltransferase inhibitors
TargetsCeramide glucosyltransferase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCerrx Inc
China Registration ClassN/A

Develop Information

Active CompaniesCerrx Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A